In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery
- PMID: 17344906
- DOI: 10.1038/sj.gt.3302920
In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery
Abstract
RNA interference (RNAi)-mediated gene silencing approaches appear very promising for therapies based on the targeted inhibition of disease-relevant genes. The major hurdle to the therapeutic development of RNAi strategies remains, however, the efficient delivery of the RNAi-inducing molecules, the short interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs), to the target tissue. With respect to cancer treatment the development of efficient delivery methods into solid tumors appears as a critical issue. However, very few studies have addressed this problem. In this study we have investigated the contribution of electrically mediated delivery of siRNA into murine tumors stably expressing an enhanced green fluorescent protein (EGFP) target reporter gene. The silencing of EGFP gene expression was quantified over time by fluorescence imaging in the living animal. Our study indicates that electric field can be used as an efficient method for siRNA delivery and associated gene silencing into cells of solid tumors in vivo.
Similar articles
-
Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery.Gene Ther. 2005 Feb;12(3):246-51. doi: 10.1038/sj.gt.3302405. Gene Ther. 2005. PMID: 15592423
-
Optical in vivo imaging of electrically mediated delivery of siRNA into muscle for gene function analysis.Methods Mol Biol. 2008;423:279-87. doi: 10.1007/978-1-59745-194-9_20. Methods Mol Biol. 2008. PMID: 18370206
-
Targeted gene silencing into solid tumors with electrically mediated siRNA delivery.Methods Mol Biol. 2009;555:15-27. doi: 10.1007/978-1-60327-295-7_2. Methods Mol Biol. 2009. PMID: 19495685
-
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.J Biotechnol. 2006 Jun 25;124(1):12-25. doi: 10.1016/j.jbiotec.2005.12.003. Epub 2006 Jan 18. J Biotechnol. 2006. PMID: 16413079 Review.
-
Nonviral in vivo delivery of therapeutic small interfering RNAs.Curr Opin Mol Ther. 2007 Aug;9(4):345-52. Curr Opin Mol Ther. 2007. PMID: 17694447 Review.
Cited by
-
Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer.J RNAi Gene Silencing. 2013 Mar 15;9:479-85. eCollection 2013. J RNAi Gene Silencing. 2013. PMID: 23946765 Free PMC article.
-
Electrotransfer of siRNA to Silence Enhanced Green Fluorescent Protein in Tumor Mediated by a High Intensity Pulsed Electromagnetic Field.Vaccines (Basel). 2020 Jan 27;8(1):49. doi: 10.3390/vaccines8010049. Vaccines (Basel). 2020. PMID: 32012775 Free PMC article.
-
Physical methods of nucleic acid transfer: general concepts and applications.Br J Pharmacol. 2009 May;157(2):207-19. doi: 10.1111/j.1476-5381.2009.00032.x. Epub 2009 Jan 21. Br J Pharmacol. 2009. PMID: 19154421 Free PMC article. Review.
-
The advancement of siRNA-based nanomedicine for tumor therapy.Nanomedicine (Lond). 2024;19(21-22):1841-1862. doi: 10.1080/17435889.2024.2377062. Epub 2024 Aug 15. Nanomedicine (Lond). 2024. PMID: 39145477 Free PMC article. Review.
-
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.PLoS One. 2010 May 24;5(5):e10764. doi: 10.1371/journal.pone.0010764. PLoS One. 2010. PMID: 20520719 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical